Immune Monitoring and Flow Cytometry - Research Accomplishments
In the 2018 – 2022 period, the IMFC SR supported approximately 110 publications of which 30 in high-Impact Factor Journals:
In the 2018 – 2022 period, the IMFC SR supported approximately 110 publications of which 30 in high-Impact Factor Journals:
In the 2018 – 2022 period the MSR SR supported approximately 240 publications, of which 50 in high-Impact Factor Journals. The MSR’s high Impact Factor publications are shown below:
Zhang Z, TeSlaa T, Xu X, Zeng X, Yang L, Xing G, Tesz GJ, Clasquin MF, Rabinowitz JD. Serine catabolism generates liver NADPH and supports hepatic lipogenesis. Nat Metab. 2021;3(12):1608-20. doi: 10.1038/s42255-021-00487-4. PubMed PMID: 34845393; PMCID: PMC8721747.
Rutgers Cancer Institute is excited to announce a new organoid development shared resource (ODSR) that is being operationalized under the leadership of Faculty Director Michael Verzi.
Home | Research Accomplishments | Services & Requests | Equipment
In the 2018 – 2022 period the CGSR supported approximately 30 cancer-relevant publications, eight of which in high Impact Factor journals (IF>10) and 13 unique peer-reviewed research grant awards (three funded by the NCI).
In the 2018 – 2022 period, the GESR supported approximately 35 cancer-relevant publications, of which 8 were in high Impact Factor journals:
Tseng HC, Xiong W, Badeti S, Yang Y, Ma M, Liu T, Ramos CA, Dotti G, Fritzky L, Jiang JG, Yi Q, Guarrera J, Zong WX, Liu C, Liu D. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11(1):4810. doi: 10.1038/s41467-020-18444-2. PubMed PMID: 32968061; PMCID: PMC7511348.
In the 2018 – 2022 period, the Cancer Prevention and Outcomes Data Support Shared Resource supported 19 cancer-relevant publications:
Coups EJ, Manne SL, Ohman Strickland P, et al. Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics. Contemp Clin Trials. 2019;83:117-27. doi: 10.1016/j.cct.2019.06.014. PubMed PMID: 31255801; PMCID: PMC6690854.
The BSR serves all Rutgers Cancer Institute research programs. From 2018 to 2022, BSR statisticians have authored 140 publications. The top 25 research publications include publications include:
The Biospecimen Inventory Dashboard results from the Biomedical Informatics and the BRHS SRs. The number of tissues, blood aliquots, disease sites, and pathological features is available for viewing using Rutgers NetID. Princeton members are assigned a guest Rutgers NetID when they apply for Rutgers Cancer Institute membership.